Most recently added FAQs are in red text.
Why doesn't warfarin, apixaban or rivaroxaban ‘count’ as a ‘yes’ in the HHCDR for clot prevention?
The Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic measure is focused on appropriate first line treatment for patients with IVD and therefore includes aspirin or traditional antiplatelet therapies. Warfarin and the other medications do not meet the current criteria for Physician Quality Reporting System (PQRS) reporting on which the HHQI Measures are based. As the national PQRS criteria are updated, the HHQI Measures will be updated to align.
© Copyright 3/21/2016 3:20:03 PM Quality Insights. Report errors to HHQI@qualityinsights.org.
Last Updated 3/21/2016 3:20:03 PM